Se-Cure Pharmaceuticals current pipeline comprises 6 botanical drug candidates, targeting women’s health and osteoporosis management, benign hyperplasia (BPH) management (male health), burn injury management and dental bone rejuvenation.
Disclaimer: Information on this web site is provided for informational
purposes only and is not intended as a substitute for the advice provided by your
physician or other healthcare professional. You should not use the information on
this web site for diagnosing or treating a health problem or disease, or prescribing
any medication or other treatment.